Page 316 - fbkCardioDiabetes_2017
P. 316

292                      Cardio Diabetes Medicine 2017





              “The initial antihypertensive drug should be started at  Individual class of drugs:
              the lowest dose and gradually increased depending   A. Diuretics:
              on the BP response to the maximum tolerated dose.
              If the anti hypertensive response to the initial drug is   Decrease  blood volume,  decrease  peripheral  resis-
              inadequate after  reaching full dose  (not  necessarily   tance  and so  BP.They  are  Very  effective in elderly
              maximum recommended dose), a second drug from      with stiff peripheral artery. But at the same time caus-
              another  class should be added, provided  the  initial   es increase of age related physiological changes and
              drug  is  tolerated. If the person  is  having no thera-  further depletion of blood volume, increase postural
              peutic response or significant adverse effects, a drug   hypotension. Electrolyte imbalance causing more ar-
              from another class should be substituted. If a diuretic   rhythmia. Impaired  glucose  tolerance, hyperuricae-
              is  not  the initial drug, it is  usually indicated  as the   mia, hypokalaemia.  hypomagnesimia  .But thiazide
              second drug.  If  the antihyperten-  sive  response  is   diuretics maintain BMD and increase blood Calcium
              inadequate after reaching the full dose of 2 classes   level. Loop diuretics decrease blood Ca level.
              of drugs, a third drug from another class should be   B. Ca Channel blocker:
              added. When the BP  is  20/10 mm Hg  above goal,
              drug therapy should generally be initiated with 2 an-  It is effective in elder population because of increased
              tihypertensive drugs, 1 of which should be a thiazide   vascular  stiffness  ,decreased vascular  compliance  ,
              diuretic;  however, in the  elderly,  treatment  must  be   diastolic dysfunction  .  Adverse  effects are  postural
              individualized .’’                                 hypotension, ankle edema, headache. These are ef-
                                                                 fective in preventing dementia.
              As per JNC 8,
                                                                 C. ACEI and ARBs:
              “In the general nonblack population, including those
              with diabetes,  initial antihypertensive  treatment   Reduce peripheral resistance without reflex stimula-
              should include a thiazide-type diuretic, calcium chan-  tion of HR and contractility.
              nel blocker (CCB), angiotensin-converting enzyme in-  Indications  are HTN  with  HF / DM /Nephropathy/
              hibitor (ACEI), or angiotensin receptor blocker (ARB).  Post  AMI/  Angina and also  effective in preventing

              Moderate Recommendation Grade B                    dementia.
              In the general black population, including those with   D. Beta Blocker:
              diabetes, initial antihypertensive treatment should in-  They are not used as first choice but used when Hy-
              clude a thiazide-type diuretic or CCB.             pertension  associated with arrhythmias, Post  AMI  ,
              For general black population: Moderate Recommen-   Heart Failure, hyperthyroidism, essential tremor, anx-
              dation – Grade B                                   iety neurosis, preoperative hypertension.
              For  black patients with diabetes:  Weak  Recommen-  Adherence  is  most important issue  in  eldely  hyper-
              dation – Grade C”                                  tension. Frequent  non-adherence  and non-control
                                                                 of  BP  occur due  to dementia,  Low  socio-economic
              As per Indian Hypertension Guidelines-III,         condition, isolation, Cost, Side effects, Treating com-
              Elderly hypertensives should be started with Calcium   plications and all  these  issues  are  to be  addressed
              Channel blocker or Diuretic.                       while dealing a older hypertensive.

              Summary of all guidelines:                         References:
                - Start with small dose                          1.  Puspanjali S, TP Sherin Raj. Demography of aging in India. Indian Journal
                                                                   of Gerontology 2005;19:327-42.
                - Increase gradually with monitoring             2.  Franlin SS, Jacobs MJ, Wong ND, L’Italian GL, Lapuerta P. Predominance
                                                                   of isolated systolic hypertension among middle age and elderly US hyper-
                - Add next drug if not controlled                  tensives  analysis  based on National Health and Nutrition  Examination
                - Observe side  effects and  drug interaction  , non-  Survey(NHANES) III. Hypertension 2001;37:869-74.
                compliance                                       3.  Franklin SS, Khan  SA,  Wong ND, Larson MG, levy D. Is pulse pressure
                                                                   more important than systolic blood pressure in predicting coronary heart
                - Choice of drug according to concomitant diseases   disease event. Circulation 1999;100:354-60.
                and other duugs.
                                                                 4.  Dalal PM. Hypertension  – A report on community survey  for casual hy-
                - Ordinarily  ca- channel  blockers  and diuretcs are   pertension in old Bombay. Ed H Jhala Bombay Sir HN Hospital 1980.
                1  line of choice.                               5.  Reaven GM. Insulin resistance, hyper-insulinemia and hyper-triglyceridemia
                 st
                                                                   in the etiology clinical course of hypertension. Am J Med 1991;90:7S-12S.

                                                         GCDC 2017
   311   312   313   314   315   316   317   318   319   320   321